Please provide your email address to receive an email when new articles are posted on . LOUISVILLE, Ky. — Patients with asthma had a greater risk for ischemic heart disease compared with those without ...

December 8, 2010 — Compared with low doses, moderate doses of inhaled corticosteroids (ICSs) may not give an added benefit to children with mild to moderate persistent asthma, according to the results ...

In many patients, annual short-acting beta2-agonist prescription fulfillment is indicative of uncontrolled disease and increased incidence of exacerbations. Credit: Getty Images. Short-acting beta ...

Please provide your email address to receive an email when new articles are posted on . Rademikibart improved lung function and asthma control in adults with moderate to severe persistent asthma. The ...

The global trial met its primary endpoint showing both doses of rademikibart treatment significantly improved lung function at Week 12 The significant improvement in lung function was observed as ...

The Food and Drug Administration has approved Celltrion’s Omlyclo (omalizumab-igec) as a biosimilar designated as interchangeable with Xolair (omalizumab) for the treatment of moderate to severe ...

Women who work night shifts are more likely to suffer with moderate or severe asthma compared to women who work in the daytime, according to a study published today (Monday) in ERJ Open Research [1].

An increased need for short-acting beta 2 -agonists more than two days a week for acute symptom relief signifies asthma is not controlled, and therapy should be adjusted accordingly. Systemic ...

The ability of four different asthma assessment tools to predict each of five adverse clinical asthma outcomes was modeled using both logistic regression and CART analysis using data collected for non ...

Despite a wealth of available treatments to control the symptoms of chronic asthma, the lung disease has no cure. The discovery of an unexpected cause of asthma could change that. A glitch in the ...

"Our findings indicate the need for comprehensive approaches to managing allergic rhinitis with comorbid conditions, to avoid its aggravation."– Isabella Annesi-Maesano, MD, Institut Desbrest of ...